Chronic total occlusion of renal artery in symptomatic young patient with resistant hypertension: is a revascularization necessary or redundant?
Wojciech Stecko,Piotr Wańczura,Adam Wajhajmer,Mateusz Wiśniowski,David Aebisher
DOI: https://doi.org/10.1097/hjh.0000000000003846
IF: 4.9
2024-12-04
Journal of Hypertension
Abstract:Renal artery stenosis (RAS) refers to the presence of a lesion that narrows the vessel lumen by at least 60%, the hemodynamic significance of which can be further confirmed by determining the pressure gradient with endovascular methods [1] . It can occur in up to 5–10% of the general population, and its main cause is the presence of atherosclerotic plaque. Thus, the prevalence of the disease increases with age and correlates with the presence of cardiovascular risk factors: hypertension, dyslipidemia, smoking, male sex, diabetes, chronic kidney disease or a family history. In 20%, it occurs bilaterally or involves the single functioning kidney. Rarer causes include fibromuscular dysplasia (FMD), a history of or active vasculitis including the presence of Takayasu arteritis (type 3, 4 or 5 disease). FMD occurs in a younger population, is nine times more common in women and is more common in people without cardiovascular risk factors, except for smoking, which contributes to its occurrence. It develops in less than 1% of the general population and is usually diagnosed in the fifth decade of life, often incidentally during diagnostic imaging performed for other clinical indications, but cases diagnosed in childhood have also been described. The pathogenesis of FMD is not fully understood. There are suggestions that it is related to the presence of genetic and environmental factors, smoking and estrogens [1,2] . In 10%, the disease occurs in a family member. FMD takes the form of narrowing or widening (ectasias, aneurysms) of medium-sized arteries, and the sudden dissection of the vessel at the site of the primary lesion may occur. The condition most often affects the arteries of the central nervous system and renal arteries, less often other locations in the abdomen and vessels of the extremities. RAS, regardless of the cause, can lead to a number of adverse consequences. Reducing the flow behind the stenosis results in increased secretion of renin in the affected kidney, which leads to the activation of the renin-angiotensin-aldosterone system (RAAS) and the sympathetic nervous system and consequently the development of secondary hypertension and increased cardiovascular risk. RAS is the most common form of renovascular hypertension and one of the most common (5–28%) of secondary hypertension in general [3] . Progressive renal ischemia may contribute to the deterioration of its excretory function and lead to chronic kidney disease and, in advanced cases, to loss of function and atrophy of the organ. During RAS, there may also be recurrent pulmonary oedema with abrupt onset (flash pulmonary edema), and in those cases, exclusion of structural disease in the heart suggests the presence of RAS. Other conditions that raise suspicion of renal artery disease include onset of hypertension less than 30 years of age, rapid acceleration of previously well controlled blood pressure, onset of resistant hypertension, hypertensive crisis (acute heart failure, hypertensive encephalopathy), unexplained renal atrophy or disproportion in kidney size, unexplained kidney failure, worsening of kidney function after starting an angiotensin-converting enzyme inhibitor (ACEi) or an angiotensin-receptor blocker (ARB).
peripheral vascular disease